- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mo | Major trial launched to explore GLP-1 benefit in dementia | ||
| Mo | GSK to file Jemperli for rectal cancer after phase 3 readout | ||
| Mo | EU warns of brain tumour risk with some contraceptives | ||
| Mo | Pay offer rejected as ICR researchers continue strike action | ||
| Mo | Sleep apnoea drug firm Apnimed files for IPO | ||
| Fr | Non-profit DNDi preps phase 3 trials for dengue antibody | ||
| Fr | Bausch + Lomb drug fails in glaucoma, but a new use beckons | ||
| Fr | Roche abandons two Huntington's drug candidates | ||
| Fr | Bayer gets €3bn from Apollo for contraceptives unit stake | ||
| Do | Moderna's mResvia gets shot in the arm from EU contract | ||
| Do | Keenova eyes Xiaflex as first drug for plantar fibromatosis | ||
| Do | GSK ends dementia alliance with Alector after setbacks | ||
| Do | NICE aims to cut funding for Amgen lung cancer drug Lumykras | ||
| Do | AZ, Ionis hit by unexpected Wainua trial failure | ||
| Do | UK first in Europe to clear Boehringer's IPF drug Jascayd | ||
| Mi | Aureka offers open-source AI module for drug discovery | ||
| Mi | AZ pays $200m upfront for Sino Bio COPD drug | ||
| Mi | EU seeks advice on Sanofi's response to mismarketing claim | ||
| Mi | Otsuka's Voyxact faces rival as FDA okays Vera IgAN drug | ||
| Mi | Kailera's big obesity reveal puts pressure on shares | ||
| 07.07. | Obesity biotech Kalohexis files confidential IPO | ||
| 07.07. | Island Pharma drug cleared for Bundibugyo Ebola use | ||
| 07.07. | With measles cases rising, UK launches vaccination drive | ||
| 07.07. | NICE backs NHS use of non-invasive endometriosis tests | ||
| 07.07. | Vertex buys Crinetics for $10bn in endocrinology drive |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.